Bilirubin is a biomarker for the diagnosis of liver diseases or bile duct dysfunction. This study assessed the physiological changes in the blood bilirubin level infusing ω-3 enriched parenteral nutrition (PN) and ω-3 free PN in healthy male subjects.
This study was a randomized, open-label, two-treatment, two-way crossover trial. Sixteen subjects were assigned randomly to one of two sequences of the two treatments: ω-3 enriched PN or ω-3 free PN was infused via aperipheral venous catheter for six hours at 3 mL/kg/h. Blood samples were collected every one hour from 0 to 12 hours after starting an intravenous infusion for bilirubin concentrations. The total bilirubin and direct bilirubin concentrations in the blood were analyzed using an enzymatic method.
The bilirubin concentration in the blood was reduced while infusing the ω-3 enriched PN and ω-3 free PN. When it stopped infusing, the bilirubin concentration was recovered. A similar pattern was observed, but there was a further decline and recovery in ω-3 free PN.
When ω-3 enriched PN and ω-3 free PN are infused in healthy male subjects, the blood bilirubin level decreasedand there is no difference between the two groups.
Nutrition therapy is a critical component of treatment for patients with acute respiratory distress syndrome/acute lung injury. Underfeeding can cause cumulative caloric deficits, loss of lean body mass, and deteriorationof respiratory muscle strength, which can all lead to poor outcomes. However, overfeeding, on the other hand, is also harmful due to hypercapnia and hyperglycemia, which can increase the risk of infection. Therefore, an optimal nutrition therapy is very important. Although the importance of nutrition in this patient population is widely accepted, trophic enteral feeding during the acute phase is suggested in immunologic aspect to prevent nutrition-related complications. High-fat and low-carbohydrate enteral nutrition can decrease CO2 production and help shorten the duration of mechanical ventilation in patients with acute respiratory distress syndrome. There are still areas of controversy regarding the role of omega-3 fatty acids and antioxidants, which are known to prevent oxidative cellular injury, modify the metabolic response, and modulate immunity and inflammation.